Overview

Study of CTS-1027 in Hepatitis C Patients

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if CTS-1027 can lower elevated liver enzymes in patients with chronic HCV infection.
Phase:
Phase 2
Details
Lead Sponsor:
Conatus Pharmaceuticals Inc.
Collaborator:
FGK Clinical Research GmbH